Cargando…
Exendin-4 for Parkinson's disease
This review article discusses the preclinical evidence and clinical trials testing the use of a peptide agonist of the glucagon-like peptide (GLP) receptor that promotes insulin secretion in the animal models of and patient with Parkinson's disease (PD). In particular, we focus on the therapeut...
Autores principales: | Esparza-Salazar, Felipe de Jesús, Lezama-Toledo, Alma Rosa, Rivera-Monroy, Germán, Borlongan, Cesario V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057099/ https://www.ncbi.nlm.nih.gov/pubmed/34084977 http://dx.doi.org/10.4103/bc.bc_21_21 |
Ejemplares similares
-
Gut–Brain Axis as a Pathological and Therapeutic Target for Neurodegenerative Disorders
por: Toledo, Alma Rosa Lezama, et al.
Publicado: (2022) -
Inflammatory gut as a pathologic and therapeutic target in Parkinson’s disease
por: Lee, Jea-Young, et al.
Publicado: (2022) -
Combination of Stem Cells and Rehabilitation Therapies for Ischemic Stroke
por: Berlet, Reed, et al.
Publicado: (2021) -
Treating Metastatic Brain Cancers With Stem Cells
por: Sadanandan, Nadia, et al.
Publicado: (2021) -
IL-2/IL-2R Antibody Complex Enhances Treg-Induced Neuroprotection by Dampening TNF-α Inflammation in an In Vitro Stroke Model
por: Borlongan, Mia C., et al.
Publicado: (2021)